Basilea shareholders approve all proposals of the board of directors at the annual general meeting

24.04.2024 - Allschwil, Switzerland, April 24, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, reported that shareholders ...

Related Keywords

Switzerland ,Allschwil ,Switzerland General ,Basilea ,Basel Stadt ,Swiss ,Martin Nicklasson ,Caroline Cron ,Nicole Onetto ,Thomas Werner ,Domenico Scala ,Leonard Kruimer ,Nils Schr ,Head Of Corporate Communications Investor Relations ,Pricewaterhousecoopers Ltd ,Swiss Exchange ,Basilea Pharmaceutica International Ltd ,Basilea Pharmaceutica Ltd ,Carole Sable ,Corporate Communications ,Pharmaceutica International Ltd ,